Chronic venous ulceration of the lower limbs and thrombosis

Acta Phlebologica

Volumn 15, Issue 2, 2014, Pages 49-55

  De Franciscis, S ^a   Grande, R ^a   Buffone, G ^a   Serra, R ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Thrombophilia; Thrombosis; Varicose ulcers; Veins

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ANTITHROMBIN DEFICIENCY; ARTICLE; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; INJURY; LEG THROMBOSIS; LEG ULCER; MEDLINE; NEOPLASM; OBESITY; PREGNANCY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; SCIENCEDIRECT; SCOPUS; SYSTEMATIC REVIEW; THROMBOPHILIA;

EID: 84919353030     PISSN: 1593232X     EISSN: 18271766     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21:395-401.
2. Serra R, Gallelli L, Buffone G, Molinari V, Stillitano DM, Palmieri C et al. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013 [Epub ahead of print].
3. Serra R, Buffone G, Costanzo G, Montemurro R, Perri P, Damiano R et al. Varicocele in younger as risk factor for inguinal hernia and for chronic venous disease in older: preliminary results of a prospective cohort study. Ann Vase Surg 2013;27:329-31.
4. Serra R, Buffone G, de Franciscis A, Mastrangelo D, Molinari V, Montemurro R et al. A genetic study of chronic venous insufficiency. Ann Vase Surg 2012;26:636-42.
5. Mackenzie RK, Ludlam CA, Ruckley CV, Allan PL, Burns P, Bradbury AW. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vase Surg 2002;35:718-22.
6. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL et al.; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vase Surg 2004;40:1248-52.
7. Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
8. Calistru AM, Baudrier T, Gonçalves L, Azevedo F. Thrombophilia in venous leg ulcers: a comparative study in early and later onset. Indian J Dermatol Venereol Leprol 2012;78:406.
9. Karathanos Ch, Sfyroeras G, Drakou A, Roussas N, Exarchou M, Kyriakou D et al. Superficial vein thrombosis in patients with varicose veins: role of thrombophilia factors, age and body mass. Eur J Vase Endovasc Surg 2012;43:355-8.
10. Rabinovich A, Kahn SR. Association between Thrombophilia and the Post-Thrombotic Syndrome. Int J Vase Med 2013;2013:64 3036.
11. Serra R, Buffone G, Molinari V, Montemurro R, Perri P, Stillitano DM et al. Low molecular weight heparin improves healing of chronic venous ulcers especially in the elderly. Int Wound J 2013 [Epub ahead of print].
12. de Franciscis S, De Sarro G, Longo P, Buffone G, Molinari V, Stillitano DM et al. Hyperhomocysteinaemia and chronic venous ulcers. Int Wound J 2013 [Epub ahead of print].
13. Serra R, Buffone G, de Franciscis A, Mastrangelo D, Vitagliano T, Greco M et al. Skin grafting followed by low-molecular-weight heparin long-term therapy in chronic venous leg ulcers. Ann Vase Surg 2012;26:190-7.
14. Hepner M, Karlaftis V. Antithrombin. Methods Mol Biol 2013;992:355-64.
15. Milio G, Siragusa S, Malato A, Grimaudo S, Pinto A. Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins. Int Angiol 2009;28:298-302.
16. Pereira de Godoy JM, Andrade Torres CA, Braile DM. Prevalence of antithrombin deficiency in patients with chronic leg ulcer. Blood Coagul Fibrinolysis 2001;12:593-5.
17. Tassin M, Llarena P, Laffaye F, Kaltenbach G. Protein C deficiency in patient with sepsis-associated disseminated intravascular coagulation and deep vein thrombosis. Arch Argent Pediatr 2013;111:e28-30.
18. Tsutsui K, Ishida W, Ohashi T, Takehara K. Hereditary type lib protein S deficiency in a patient with recurrent venous ulcers. Dermatol 1997;194:198-9.
19. Kujovich JL. Factor V leiden thrombophilia. Genet Med 2011;13:1-16.
20. Peus D, von Schmiedeberg S, Pier A, Scharf RE, Weheimer A, Ruzicka T et al. Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression. J Am Acad Dermatol 1996;35:306-9.
21. Boisseau MR. Venous valves in the legs: hemodynamic and biological problems and relationship to physiopathology. J Mai Vase 1997;22:122-7.
22. Gaber Y, Siemens HJ, Schmeller W. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers. Br Dermatol 2001;144:546-8.
23. Sule AA, Chin TJ, Khien LH. Recurrent unprovoked venous thromboembolism in a young female patient with high levels of homocysteine. Int J Angiol 2012;21:95-8.
24. Sykes TC, Fegan C, Mosquera DA. Thrombophilia, polymorphisms and Vascular Disease. Mol Pathol 2000;53:300-6.
25. Durmazlar SP, Akgul A, Eskioglu F. Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications. J Dermatolog Treat 2009;20:336-9.
26. Schwartzfarb EM, Romanelli P. Hyperhomocysteinemia and lower extremity wounds. Int J Low Extrem Wounds 2008;7:126-36.
27. Jebeleanu G, Procopciuc L. G20210A prothrombin gene mutation identified in patients with venous leg ulcers. J Cell Mol Med 2001;5:397-401.
28. Mirrakhimov AE, Velasquez Kho E, Ali A. Painless livedoid vasculopathy in a patient with G20210A prothrombin gene mutation. Case Rep Med 2012;2012:910231.
29. Garcia D, Akl EA, Carr R, Kearon C. Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review. Blood 2013 [Epub ahead of print].
30. Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism. Br J Haematol 2002;118:1166-9.
31. Rangel ML, Alghamdi I, Contreras G, Harrington T, Thomas DB, Barisoni L, Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations. Lupus 2013;22:855-64.
32. Skare TL, Ribas CA, Malafaia O, Ribas Filho JM, Nassif PA, Nascimento MM et al. Anticardiolipin antibodies in leg ulcers. Rev Col Bras Cir 2009;36:152-6.
33. Alcaraz I, Levfevre I, Wiart T, Lafon C, Forzy G, Modiano P. Leg ulcers and antiphospholipid antibodies. Prospective study of 48 cases. Annal Dermatol et de Venereol 1999;126:313-6.
34. Diógenes MJ, Diógenes PC, de Morais Carneiro RM, Neto CC, Duarte FB, Holanda RR. Cutaneous manifestations associated with antiphospholipid antibodies. Int J Dermatol 2004;43:632-7.
35. Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998;92:2353-8.
36. Dissemond J, Knab J, Lehnen M, Goos M. Increased activity of factor VIII coagulant associated with venous ulcer in a patient with Klinefelter's syndrome. J Eur Acad Dermatol Venereol 2005;19:240-2.
37. Darvall KA, Sam RC, Adam DJ, Silverman SH, Fegan CD, Bradbury AW. Higher prevalence of thrombophilia in patients with varicose veins and venous ulcers than controls. J Vase Surg 2009;49:1235-41.
38. Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A et al. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 2010;16:184-8.
39. Calistru AM, Cruz MJ, Baudrier T, Gonçalves L, Azevedo F. Leg ulcers revealing familial thrombophilia: prothrombin G20210A gene mutation and plasminogen activator inhibitor type 1 (PAI-1) polymorphism. Eur J Dermatol 2011;21:414-5.
40. Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A 2012;109:13076-8.
41. Erfurt-Berge C, Bauerschmitz J. Malignant tumours arising in chronic leg ulcers: three cases and a review of the literature. J Wound Care 2011;20:396-400.
42. Morange PE, Alessi MC. Thrombosis in central obesity and metabolic syndrome: Mechanisms and epidemiology. Thromb Haemost 2013;110(3).
43. Musil D, Kaletova M, Herman J. Age, body mass index and severity of primary chronic venous disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011;155:367-71.
44. Abbade LP, Lastória S, Rollo Hde A. Venous ulcer: clinical characteristics and risk factors. Int J Dermatol 2011;50:405-11.
45. Wik HS, Jacobsen AF, Fagerland MW, Sandvik L, Sandset PM. Long-term mortality and incidence of cancer after pregnancy-related venous thrombosis: Results of a population-based cohort study. Thromb Res 2013;131:497-501.
46. Kasperczak J, Ropacka-Lesiak M, Breborowicz HG. Definition, classification and diagnosis of chronic venous insufficiency - part II. Ginekol Pol 2013;84:51-5.
47. Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC et al. Risk of venous thrombosis in patients with major illnesses: results from the MEGA study. J Thromb Haemost 2013;11:116-23.
48. Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med 2011;124:756-65.
49. Mackenzie RK, Ludlam CA, Ruckley CV, Allan PL, Burns P, Bradbury AW. The prevalence of thrombophilia in patients with chronic venous leg ulceration. J Vase Surg 2002;35:718-22.
50. Bradbury AW, MacKenzie RK, Burns P, Fegan C. Thrombophilia and chronic venous ulceration. Eur J Vase Endovasc Surg 2002;24:97-104.